文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists.

作者信息

Douglass Amber R, Maister Ashley, Moeller Karen E, Salwan Aaron, Vallabh Anuja, Waters Kristin, Payne Gregory H

机构信息

Clinical Pharmacist Practitioner - Mental Health, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.

Clinical Professor, University of Kansas, Kansas City, Kansas.

出版信息

Ment Health Clin. 2024 Aug 2;14(4):253-266. doi: 10.9740/mhc.2024.08.253. eCollection 2024 Aug.


DOI:10.9740/mhc.2024.08.253
PMID:39104432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11298032/
Abstract

Deaths related to opioid overdoses continue to climb, and there remains a need for innovative strategies to address this ongoing crisis. Harm reduction (HR), a nonjudgmental philosophy aimed at reducing consequences associated with drug use and other potentially unsafe behavior, has emerged as a compassionate and effective approach. Harm reduction further emphasizes overdose prevention and fosters a shift in perspective that recognizes substance use disorder as a disease and not a moral failing. The tenets of HR collectively advocate for the well-being of individuals who use substances and support any positive change as defined by the individual. Given the high rate of morbidity and mortality associated with substance misuse and barriers or ambivalence to receiving treatment, awareness of and advocacy for HR practice is essential. This manuscript aims to describe evidence-based HR interventions, provide a foundation for the implementation of services, and further promote the importance of providing humanistic care without judgment. As valued members of the multidisciplinary treatment team, Board-Certified Psychiatric Pharmacists should implement and engage in HR services in the settings where people with substance use disorders receive care.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/11298032/491fe0f7fa29/i2168-9709-14-4-253-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/11298032/491fe0f7fa29/i2168-9709-14-4-253-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/11298032/491fe0f7fa29/i2168-9709-14-4-253-f01.jpg

相似文献

[1]
Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists.

Ment Health Clin. 2024-8-2

[2]
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.

Med J Aust. 2019-11

[3]
Promoting harm reduction in rural South Dakota using an interdisciplinary consortium.

J Am Pharm Assoc (2003). 2023

[4]
Take care of the patient: Pharmacists should advocate for overdose prevention centers as harm reduction.

J Am Pharm Assoc (2003). 2025

[5]
Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment.

J Gen Intern Med. 2021-12

[6]
Implementation of harm reduction services for people who use drugs provided by pharmacy staff: a scoping review protocol.

BMJ Open. 2025-3-21

[7]
Harm Reduction as an Essential Psychiatric Mental Health Nursing Skill.

J Am Psychiatr Nurses Assoc. 2025-4-12

[8]
Community pharmacists' attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey.

Harm Reduct J. 2024-7-19

[9]
Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction.

J Am Pharm Assoc (2003). 2022

[10]
How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.

Harm Reduct J. 2024-5-11

引用本文的文献

[1]
Potential changes impacting psychiatric pharmacy by 2030.

Ment Health Clin. 2025-2-3

本文引用的文献

[1]
Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey.

Int J Drug Policy. 2023-6

[2]
Psychotropic stewardship: Advancing patient care.

Ment Health Clin. 2023-4-12

[3]
Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking.

Harm Reduct J. 2023-3-28

[4]
The role of community pharmacies in the HIV and HCV care continuum.

Explor Res Clin Soc Pharm. 2023-1-11

[5]
Contraception use among individuals with substance use disorder increases tenfold with patient-centered, mobile services: a quasi-experimental study.

Harm Reduct J. 2023-3-6

[6]
Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips.

Drug Alcohol Depend Rep. 2022-6-30

[7]
Clarifying 'safer supply' to enrich policy discussions.

Addiction. 2023-6

[8]
Pharmacists and Naloxone: Barriers to Dispensing and Effectiveness of an Educational Outreach Program.

J Am Pharm Assoc (2003). 2023

[9]
The Role of the Pharmacist in Combating the Opioid Crisis: An Update.

Subst Abuse Rehabil. 2022-12-28

[10]
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2023.

Diabetes Care. 2023-1-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索